Last Nucleotide Substitutions of COL4A5 Exons Cause Aberrant Splicing-Reference-Cited by-同舟云学术

Last Nucleotide Substitutions of COL4A5 Exons Cause Aberrant Splicing

Published:2022-01 Issue:1 Volume:7 Page:108-116
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Aoto Yuya^ORCID,Horinouchi Tomoko,Yamamura Tomohiko,Kondo Atsushi,Nagai Sadayuki,Ishiko Shinya,Okada Eri^ORCID,Rossanti Rini,Sakakibara Nana^ORCID,Nagano China^ORCID,Awano Hiroyuki,Nagase Hiroaki,Shima Yuko,Nakanishi Koichi,Matsuo Masafumi,Iijima Kazumoto,Nozu Kandai

Publisher

Elsevier BV

Subject

Nephrology

Reference48 articles.

1. Alport syndrome;Kashtan,1993

2. A review of clinical characteristics and genetic backgrounds in Alport syndrome;Nozu;Clin Exp Nephrol,2019

3. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males;Jais;J Am Soc Nephrol,2000

4. Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome;Yamamura;Kidney Int,2020

5. Genotype-phenotype correlation in X-linked Alport syndrome;Bekheirnia;J Am Soc Nephrol,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome;Nephrology Dialysis Transplantation;2024-08-12

2. Synonymous variant at the terminal nucleotide in exon 3 of F7 causes abnormal splicing: A case report;Molecular Genetics & Genomic Medicine;2024-07

3. Evaluation of pathogenicity of WT1 intron variants by in vitro splicing analysis;Clinical and Experimental Nephrology;2024-06-14

4. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family;Gene;2024-05

5. Molecular and in silico investigation of a novel ECHS1 gene mutation in a consanguine family with short-chain enoyl-CoA hydratase deficiency and Mt-DNA depletion: effect on trimer assembly and catalytic activity;Metabolic Brain Disease;2024-02-16